Insiders Myriad Genetics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-03 pm EDT			5-day change	1st Jan Change
22.35 ^USD	-1.80%		-3.50%	+16.77%

May. 31	Qiagen, Myriad Genetics Team Up to Develop Homologous Recombination Deficiency Test	MT
May. 31	Qiagen, Myriad Genetics Partner to Create Easily Distributable Cancer Tumor Test	MT

Myriad Genetics Names George Daneker Jr. as President, Chief Clinical Officer of Oncology	Jan. 31	MT
Myriad Genetics, Inc. Appoints George Daneker as President and Chief Clinical Officer of Oncology, Effective March 18, 2024	Jan. 30	CI
Myriad Genetics Names Scott Leffler as Chief Financial Officer, Reiterates Outlook	Dec. 21	MT
Myriad Genetics Insider Sold Shares Worth $470,622, According to a Recent SEC Filing	Nov. 03	MT
Myriad Genetics Names Sam Raha as Chief Operating Officer	Nov. 01	MT
Myriad Genetics, Inc. Appoints Samraat S. Raha as Chief Operating Officer, Effective as of December 11, 2023	Nov. 01	CI
Myriad Genetics COO Nicole Lambert to Step Down	23-10-05	MT
Myriad Genetics, Inc. Announces Executive Changes	23-10-05	CI
Insider Sell: Myriad Genetics	23-06-05	MT
Myriad Genetics, Inc. Appoints Adam Brufsky as Scientific Advisor	23-05-31	CI
Insider Sell: Myriad Genetics	23-03-28	MT
Insider Sell: Myriad Genetics	23-03-03	MT
Insider Sell: Myriad Genetics	23-03-03	MT
Insider Sell: Myriad Genetics	23-01-23	MT
Insider Sell: Myriad Genetics	22-12-28	MT
Myriad Genetics, Inc. Hires Senior Leaders to Advance Commercial Growth Plans	22-12-19	CI
Myriad Genetics, Inc. Elects Paul M. Bisaro as New Board Member	22-10-31	CI
Myriad Genetics, Inc. Announces the Resignation of Dennis Langer as Director	22-06-30	CI
Myriad Genetics, Inc. Announces Executive Changes	22-06-02	CI
Myriad Genetics Named to Fast Company’s Annual List of World’s Most Innovative Companies	22-03-08	GL

No results for this search